Posted by Michael Wonder on 16 May 2022
EMA publishes agenda for 16-19 May 2022 CHMP meeting
16 May 2022 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue opinions for the following technologies:
- Eptacog beta (activated)
- Ertapenem sodium
- Ganirelix acetate
- Trastuzumab
- Budesonide
- Sitagliptin with metformin hydrochloride
- Sugammadex
- eladocagene exuparvovec
- Olipudase alfa
- Lonafarnib
